3B BLACKBIO DX LTD. (3BBLACKBIO) financials

3B BLACKBIO DX LTD. (3BBLACKBIO) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2011, 3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, and agrochemical-based products[1]

Market Cap: ₹1,143Cr.
Current Price: ₹1,331
Stock P/E: 22.4
ROE: 16.7%
ROCE: 22.4%
Book Value: ₹372
Dividend Yield: 0.38%
52W High / Low: ₹1,750/1,084

In Jun 2026, 3B BLACKBIO DX LTD. (3BBLACKBIO) reported sales ₹23 Cr and net profit ₹14 Cr.

Annual TTM: sales ₹100 Cr, net profit ₹51 Cr.

Shareholding: Promoters 40.95% (Sep 2026), FIIs 2.46% (Sep 2026), DIIs 2.33% (Sep 2026), Public 54.26% (Sep 2026), No. of Shareholders 10,851% (Sep 2026).

3BBLACKBIO quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	27	23	23	20	28	24	25	23
Expenses	11	8	14	9	12	10	13	10
Operating Profit	15	15	9	12	16	14	11	13
OPM %	57%	64%	41%	57%	57%	59%	46%	58%
Other Income	3	3	5	4	4	5	1	5
Interest	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0
Profit before tax	18	18	14	16	20	19	12	18
Tax %	23%	24%	35%	21%	23%	23%	39%	23%
Net Profit	14	13	9	12	15	14	7	14
EPS in Rs	16.48	15.67	10.77	14.52	17.41	16.85	8.68	16.44
Raw PDF	—	—	—	—	—	—	—	—

3BBLACKBIO profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	14	14	16	59	71	91	97	100
Expenses	14	16	17	30	36	41	44	45
Operating Profit	-0	-1	-1	30	35	50	53	55
OPM %	-1.8%	-8%	-8%	50%	50%	55%	55%	55%
Other Income	1	4	10	7	12	15	14	15
Interest	0	0	0	0	0	0	0	0
Depreciation	0	0	0	1	1	1	1	1
Profit before tax	1	2	8	36	46	64	66	69
Tax %	0%	18%	5%	26%	26%	26%	26%	—
Net Profit	1	2	8	26	34	48	49	51
EPS in Rs	0.81	2.29	10.67	35.19	39.86	55.41	57.46	59.38
Dividend Payout %	86%	392%	98%	8%	8%	7%	9%	—

3BBLACKBIO balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6	7	7	7	9	9	9	9
Reserves	9	13	15	16	188	219	264	310
Borrowings	6	4	2	3	2	1	0	0
Other Liabilities	5	4	4	5	16	21	24	31
Total Liabilities	27	28	29	32	214	250	297	350
Fixed Assets	2	2	2	3	7	7	6	7
CWIP	0	0	0	0	0	0	0	0
Investments	1	4	4	4	102	128	167	188
Other Assets	23	22	23	25	105	116	124	155
Total Assets	27	28	29	32	214	250	297	350

3BBLACKBIO cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	0	1	3	8	21	28	44	43
Cash from Investing Activity	-0	-2	-0	-2	-8	-20	-34	-20
Cash from Financing Activity	-0	1	-2	-6	-3	-4	-3	-7
Net Cash Flow	-0	0	1	0	10	5	8	16
Free Cash Flow	0	1	3	6	20	28	44	41
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	107%	-458%	-264%	-663%	102%	112%	119%	111%

3BBLACKBIO shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	41.28%	41.28%	41.28%	41.28%	41.27%	40.94%	40.95%	40.95%
FIIs	2.68%	2.49%	2.70%	2.64%	2.57%	2.57%	2.50%	2.46%
DIIs	1.74%	1.60%	1.76%	1.82%	1.87%	1.98%	2.15%	2.33%
Public	54.29%	54.64%	54.28%	54.26%	54.27%	54.50%	54.40%	54.26%
No. of Shareholders	10,166	10,345	10,619	10,709	10,507	10,616	11,049	10,851

3BBLACKBIO key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	426	382	358	337	206	188	142	162
Inventory Days	176	116	88	81	154	144	122	102
Days Payable	156	108	95	108	63	65	24	21
Cash Conversion Cycle	447	390	351	311	297	267	240	243
Working Capital Days	427	438	422	391	248	225	174	182
ROCE %	4%	4%	9%	34%	32%	22%	26%	22%

3BBLACKBIOUpdated 21 Oct 2026, 6:48

3b Blackbio Dx Ltd.

3BBLACKBIOUpdated 21 Oct 2026, 6:48

Market Cap

₹1,143Cr.

Current Price

₹1,331

High / Low

₹1,750/1,084

Stock P/E

22.4

ROE16.7%

ROCE22.4%

Book Value₹372

Face Value₹10.0

Dividend Yield0.38%

About

Incorporated in 2011, 3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, and agrochemical-based products[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Expenses	Other Income	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	13	7	3	9	21	7	9.95
Sep 2023	19	10	3	11	24	8	11.29
Dec 2023	17	7	2	12	22	9	10.73
Mar 2024	22	12	4	14	35	9	10.56
Jun 2024	18	7	4	14	22	11	12.5
Sep 2024	27	11	3	18	23	14	16.48
Dec 2024	23	8	3	18	24	13	15.67
Mar 2025	23	14	5	14	35	9	10.77
Jun 2025	20	9	4	16	21	12	14.52
Sep 2025	28	12	4	20	23	15	17.41
Dec 2025	24	10	5	19	23	14	16.85
Mar 2026	25	13	1	12	39	7	8.68
Jun 2026	23	10	5	18	23	14	16.44

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	18	1	17	0	0	0	21	0	0.34
Mar 2016	16	1	15	0	0	0	23	0	0.3
Mar 2017	13	1	12	0	0	0	14	0	0.36
Mar 2018	16	1	14	0	0	1	9	1	0.81
Mar 2019	12	0	12	1	0	0	2	0	0.67
Mar 2020	14	0	14	1	0	1	0	1	0.81
Mar 2021	14	0	16	4	0	2	18	2	2.29
Mar 2022	16	0	17	10	0	8	5	8	10.67
Mar 2023	59	0	30	7	1	36	26	26	35.19
Mar 2024	71	0	36	12	1	46	26	34	39.86
Mar 2025	91	0	41	15	1	64	26	48	55.41
Mar 2026	97	0	44	14	1	66	26	49	57.46
TTM	100	0	45	15	1	69	—	51	59.38

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	40.95%
FIIs	2.46%
DIIs	2.33%
Public	54.26%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	38.43%	3.38%	1.18%	56.99%
Mar 2024	41.29%	2.97%	1.89%	53.85%
Jun 2024	41.28%	3.28%	1.96%	53.48%
Sep 2024	41.28%	3.27%	1.96%	53.48%
Dec 2024	41.28%	2.68%	1.74%	54.29%
Mar 2025	41.28%	2.49%	1.6%	54.64%
Jun 2025	41.28%	2.7%	1.76%	54.28%
Sep 2025	41.28%	2.64%	1.82%	54.26%
Dec 2025	41.27%	2.57%	1.87%	54.27%
Mar 2026	40.94%	2.57%	1.98%	54.5%
Jun 2026	40.95%	2.5%	2.15%	54.4%
Sep 2026	40.95%	2.46%	2.33%	54.26%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	Investments	Other Assets	Total Assets
Mar 2015	6	4	7	7	25	3	0	22	25
Mar 2016	6	5	7	6	24	3	0	21	24
Mar 2017	6	5	8	5	24	3	1	21	24
Mar 2018	6	9	6	5	26	2	1	22	26
Mar 2019	6	9	6	5	27	2	1	23	27
Mar 2020	7	13	4	4	28	2	4	22	28
Mar 2021	7	15	2	4	29	2	4	23	29
Mar 2022	7	16	3	5	32	3	4	25	32
Mar 2023	9	188	2	16	214	7	102	105	214
Mar 2024	9	219	1	21	250	7	128	116	250
Mar 2025	9	264	0	24	297	6	167	124	297
Mar 2026	9	310	0	31	350	7	188	155	350

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	0	0	0	0
Mar 2016	1	0	-1	0
Mar 2017	0	0	0	0
Mar 2018	-1	0	1	0
Mar 2019	0	0	0	0
Mar 2020	1	-2	1	0
Mar 2021	3	0	-2	1
Mar 2022	8	-2	-6	0
Mar 2023	21	-8	-3	10
Mar 2024	28	-20	-4	5
Mar 2025	44	-34	-3	8
Mar 2026	43	-20	-7	16

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	271	303	371	332	426	382	358	337	206	188	142	162
Inventory Days	128	121	190	108	176	116	88	81	154	144	122	102
Days Payable	204	190	237	115	156	108	95	108	63	65	24	21
Cash Conversion Cycle	196	234	323	326	447	390	351	311	297	267	240	243
Working Capital Days	183	218	279	328	427	438	422	391	248	225	174	182
ROCE %	6%	5%	6%	6%	4%	4%	9%	34%	32%	22%	26%	22%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of 3B BLACKBIO DX LTD. (3BBLACKBIO)?

The reported market capitalisation for 3B BLACKBIO DX LTD. (3BBLACKBIO) is ₹1,143Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of 3BBLACKBIO?

The current price shown for 3B BLACKBIO DX LTD. (3BBLACKBIO) on Fincrux is ₹1,331 with a 52-week high/low of ₹1,750/1,084.

What is the P/E ratio of 3B BLACKBIO DX LTD. (3BBLACKBIO)?

The stock P/E for 3B BLACKBIO DX LTD. (3BBLACKBIO) is 22.4 on Fincrux, with ROE at 16.7% and ROCE at 22.4%.

What were 3BBLACKBIO latest quarterly results?

For Jun 2026, 3B BLACKBIO DX LTD. (3BBLACKBIO) reported sales ₹23 Cr and net profit ₹14 Cr (figures in ₹ crore unless noted).

What are 3BBLACKBIO annual sales and net profit?

For TTM, 3B BLACKBIO DX LTD. (3BBLACKBIO) shows sales of ₹100 Cr and net profit of ₹51 Cr on the Fincrux profit & loss statement.

Who owns 3B BLACKBIO DX LTD. (3BBLACKBIO)?

Latest shareholding for 3B BLACKBIO DX LTD. (3BBLACKBIO) on Fincrux: Promoters 40.95% (Sep 2026), FIIs 2.46% (Sep 2026), DIIs 2.33% (Sep 2026), Public 54.26% (Sep 2026), No. of Shareholders 10,851% (Sep 2026).

Where can I find 3B BLACKBIO DX LTD. (3BBLACKBIO) financials?

3B BLACKBIO DX LTD. (3BBLACKBIO) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show 3BBLACKBIO balance sheet and cash flow?

Yes. The 3B BLACKBIO DX LTD. (3BBLACKBIO) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 21 October 2026 at 6:48